Andrew I Koven's Net Worth
$6.97 Million
Who is Andrew I Koven?
Andrew I Koven has an estimated net worth of $6.97 Million. This is based on reported shares across multiple companies, which include NEUROLOGIX INC/DE, NeuroBo Pharmaceuticals, Inc., KALA BIO, Inc., Aralez Pharmaceuticals Inc., AUXILIUM PHARMACEUTICALS INC, POZEN INC /NC, SEPRACOR INC /DE/, KOS PHARMACEUTICALS INC, and INSPIRE PHARMACEUTICALS INC.
SEC CIK
Andrew I Koven's CIK is 0001258673
Past Insider Trading and Trends
2014 was Andrew I Koven's most active year for acquiring shares with 8 total transactions. Andrew I Koven's most active month to acquire stocks was the month of May. 2005 was Andrew I Koven's most active year for disposing of shares, totalling 8 transactions. Andrew I Koven's most active month to dispose stocks was the month of April. 2007 saw Andrew I Koven paying a total of $4,947,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2015 Andrew I Koven cashed out on 232,446 shares for a total of $8,491,252.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEUROLOGIX INC/DE No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeuroBo Pharmaceuticals, Inc. (NRBO) Snapshot price: $3.51
InvestorAndrew I Koven owns 17,552 units of Common Stock which is worth $61,607.52. From 2021 to 2024 Andrew I Koven acquired a total of 105,051 shares in NeuroBo Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +40.40% | 5.05K |
—
|
—
| 17.55K |
Jun 7
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KALA BIO, Inc. (KALA) Snapshot price: $6.1
InvestorAndrew I Koven owns 13,922 units of Common Stock which is worth $84,924.20. From 2017 to 2024 Andrew I Koven acquired a total of 65,862 shares in KALA BIO, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.38% | 1.75K |
—
|
—
| 13.92K |
Jun 11
| |||
Form 4
| +273.72% | 8.91K |
—
|
—
| 12.17K |
Jun 22
| |||
Form 4
| +207.26% | 2.2K |
—
|
—
| 3.26K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +89.29% | 25K |
—
|
—
| 53K |
Jun 17
| |||
Form 4
|
∞
| 28K |
—
|
—
| 28K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aralez Pharmaceuticals Inc. No price found
President & Chief Business OffAndrew I Koven owns 1,476,674 units of Common Shares and 1,183,419 units of Common Shares, without par value. From 2016 to 2018 Andrew I Koven acquired a total of 1,739,496 shares in Aralez Pharmaceuticals Inc. at a cost of $300,390.65, Andrew also disposed a total of 556,077 shares of Aralez Pharmaceuticals Inc. equalling to $1,126,473.51.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.68% | -156.57K |
$0.37 | -$58,589.62 | 1.18M |
Scheduled
|
Jun 4
| ||
Form 4
| -1.03% | -13.96K |
$0.52 | -$7,261.28 | 1.34M |
Scheduled
|
May 14
| ||
Form 4
| -0.71% | -9.74K |
$1.70 | -$16,556.30 | 1.35M |
Scheduled
|
Mar 19
| ||
Form 4
| -10.61% | -161.91K |
$1.28 | -$207,110.16 | 1.36M |
Jun 5
| |||
Form 4
| +7.71% | 109.19K |
—
|
—
| 1.53M |
May 11
| |||
Form 4
| -0.55% | -7.83K |
$2.41 | -$18,858.25 | 1.42M |
Scheduled
|
Mar 20
| ||
Form 4
| +1.42% | 20K |
$2.55 | $50,920.00 | 1.42M |
Mar 15
| |||
Form 4
| -12.80% | -206.07K |
$3.97 | -$818,097.90 | 1.4M |
Jun 3
| |||
Form 4
| +4.65% | 71.5K |
$3.49 | $249,470.65 | 1.61M |
May 12
| |||
Form 4
| +4.21% | 62.13K |
—
|
—
| 1.54M |
Mar 17
| |||
Form 4
|
∞
| 1.48M |
—
|
—
| 1.48M |
Feb 5
| |||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
EVP, CAO, GC and SecretaryAndrew I Koven used to own units in Common Stock but no longer holds any shares there. In the year 2014 Andrew I Koven acquired a total of 218,825 shares in AUXILIUM PHARMACEUTICALS INC at a cost of $2,680,312.50, Andrew also disposed a total of 180,950 shares of AUXILIUM PHARMACEUTICALS INC equalling to $6,142,012.94.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.72K |
$36.53 | -$1,414,478.13 |
0
|
Jan 29
| |||
Form 4
| -12.06% | -5.31K |
$26.69 | -$1,989,616.63 | 38.72K |
Nov 21
| |||
Form 4/A
| +86.47% | 31.5K |
—
|
—
| 67.93K |
Feb 7 - Feb 18
| |||
Form 4/A
| +29.01% | 6.38K |
—
|
—
| 28.35K |
Feb 18
| |||
Form 4
| +100.34% | 22.05K |
$28.30 | -$17,630.90 | 44.03K |
Feb 18
| |||
Form 4
| -3.98% | -911.00 |
$23.68 | -$21,572.48 | 21.98K |
Feb 7
| |||
Form 4
| -0.44% | -102.00 |
$17.15 | -$1,749.30 | 22.89K |
Jun 21
| |||
Form 4
| +2,199.00% | 21.99K |
$18.30 | -$16,653.00 | 22.99K |
Feb 7
| |||
Form 4
|
∞
| 1K |
—
|
—
| 1K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||